Source: B3C Group

Press Release: CHI Conferences : Bioprocessing Summit Europe Returns March 24-26, 2020 in Barcelona with New Analytical and Formulation Sessions

Conference to Feature New Case Studies on Cell/Gene Therapy CMC and Manufacturing, Upstream and Downstream ProcessingBARCELONA, Spain, January 21, 2020 / B3C newswire / -- Cambridge Healthtech Institute (CHI) today announced the return of Bioprocessing Summit Europe --the fastest growing bioprocessing meeting on the continent-with the addition of approximately 30 new sessions on Analytical and Formulation topics.Now in its third year, the March 24-26, 2020 conference is moving to The Crowne Plaza Barcelona-Fira Center, Barcelona, Spain, to accommodate increased registrations, which have doubled since the meeting was launched in 2018.Altogether, more than 130 presentations for senior-level scientists and technologists from industry, government and academia will focus on Upstream Processing, Downstream Processing, Cell Therapy CMC and Manufacturing, and Gene Therapy CMC and Manufacturing, as well as innovations in Analytical/Formulation areas.These sessions will provide solutions to the challenges of producing complex biologics while maximizing quality, risk management and cost-efficiency. Experts from such organizations as Novartis, Pfizer, National Institute for Bioprocessing Research and Training (NIBRT), Roche, Merck, Sanofi-Aventis and Bristol-Myers Squibb will share scientific data, insights and case studies on technologies and processes."Bioprocessing Summit Europe gives participants a rare opportunity to benchmark with their peers, and benefit from unpublished information that is inaccessible elsewhere," said Dan Barry, Senior Conference Director, CHI.The new Analytical and Formulation stream will include two tracks:Analytical Characterization-Optimizing Analytical Development and Characterization, Regulatory Considerations, Novel Protein Formats, and Impurities and Host Cell Proteins (HCPs)Formulation, Stability & Aggregation-Optimizing Formulation Development, Protein Aggregation, Advances in Stability and Degradation Testing, and Analysis of Impurities, Sub-Visible and Visible ParticlesOther conference highlights will include:Plenary Keynotes led by Ralf Schumacher, PhD, Global Head, Development Biologicals, Boehringer Ingelheim Pharma GmbH & Co. KG, and Diane Blumenthal, PhD, Head, Technical Development, Spark TherapeuticsShort Courses, Training Seminars, 40 cutting-edge exhibitors, poster sessions and 1-On-1 NetworkingFor more information, please see bioprocessingeurope.com. About Cambridge Healthtech Institute Cambridge Healthtech Institute (CHI), a division of Cambridge Innovation Institute, is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech, CROs, academia, and niche service providers. CHI is renowned for its vast conference portfolio held worldwide including PepTalk, Molecular Medicine Tri-Conference, SCOPE Summit, Bio-IT World Conference & Expo, PEGS Summit, Drug Discovery Chemistry, Biomarker World Congress, World Pharma Week, The Bioprocessing Summit, Next Generation Dx Summit, Immuno-Oncology Summit, and Discovery on Target. CHI's portfolio of products include Cambridge Healthtech Institute Conferences, Barnett International, Insight Pharma Reports, Bio-IT World, Clinical Research News and Diagnostics World. ContactDawn Ringel, Ringel [email protected] Keywords: Protein Aggregates; Proteins; Cell- and Tissue-Based Therapy; Cell Aggregation; Research; Genetic Therapy; Biological Products; Europe; Drug Compounding; Drug Formulation; Pharmaceutical Formulation; Biological Products Published by B3C newswire and shared through Newronic®

Read full article »
Est. Annual Revenue
<$1M
Agree?
Est. Employees
<10
Agree?
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100